Fusion Pharmaceuticals
Corporate brand
UnclaimedClinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals as precision medicines for cancer.
Last updated September 10, 2026
AI crawler reads
No AI crawler has read this profile yet.
Overview
Fusion Pharmaceuticals is a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals as precision medicines for the treatment of cancer. It has developed a Targeted Alpha Therapies (TAT) platform together with its proprietary Fast-Clear™ linker technology to connect alpha particle emitting isotopes to antibodies and other targeting molecules to selectively deliver therapies to tumors. The company states it is a spin-out of the Centre for Probe Development and Commercialization (CPDC).
History
Fusion Pharmaceuticals describes itself as a clinical-stage biopharmaceutical company developing next-generation radiopharmaceuticals as precision medicines for the treatment of cancer. It states that it is a spin-out of the Centre for Probe Development and Commercialization (CPDC), a manufacturer and distributor of radiopharmaceuticals. The company has developed a Targeted Alpha Therapies (TAT) platform together with its proprietary Fast-Clear™ linker technology, which is designed to connect alpha particle emitting isotopes to antibodies and other targeting molecules to selectively deliver therapies to tumors.
Products and positioning
Next-generation radiopharmaceuticals for precision medicine; targeted alpha therapeutics.
Recent events
Reported
Fusion Pharmaceuticals appoints Donald Bergstrom to its board[4]
Fusion Pharmaceuticals announced Donald A. Bergstrom's appointment as a member of its board of directors. The board's number of seats increased from eight to nine immediately before his election.
Reported
Fusion Pharmaceuticals appoints Barbara Duncan board chair[5]
Fusion Pharmaceuticals announced the appointment of Barbara Duncan as chairperson of its board, replacing Damian Lamb.
Sources6 sources
- 1The Evolution of Radiopharmaceuticals - Fusion Pharma - Homefusionpharma.com
- 2The future of radiation therapy - Fusion Pharma - Aboutfusionpharma.com
- 3Fusion Pharmaceuticalswikidata.org
- 4Fusion Pharmaceuticals任命Donald Bergstrom为董事会成员prnewswire.com
- 5Fusion Pharmaceuticals任命Barbara Duncan为董事会主席prnewswire.com
- 6Fusion Pharmaceuticals Appoints Isabelle Dussault, Ph.D. as Senior Vice President, Researchprnewswire.com
Cite this profile: Cite the canonical profile. /brand-wiki/fusion-pharmaceuticals · Editorial policy · How profiles are compiled